About Apellis Pharma (APLS)
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more
- USD46.60
- USD46.85
- USD38.22
- USD94.75
- -18.60%
- 397M
- 6.67M
- 1.23M
- 6.0B
- 19.83
- -42.70%
Stock News
2 hours ago
AMD beats on Q1 revenue and EPS, but light guidance sends stock lower
Yahoo
2 hours ago
AMD gaming revenue falls 48% year-over-year and the stock is down
CNBC
2 hours ago
Analysts Are Boosting Price Targets On These Oil and gas Stocks. Is It Time To Lock In The Dividend At Current Prices?
Yahoo
2 hours ago
Pinterest shares soar 16% on earnings beat, strong revenue growth
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
